Research funding for hospitalists is drying up fast. Sweeping federal cuts to NIH, NSF, and AHRQ have eliminated roughly $200 million in hospital-based research grants, leaving investigators scrambling. Experts say the damage is real — but alternative funding through PCORI, professional societies, pharma, and philanthropy can help keep research careers alive.
Federal research funding for hospitalists has taken a serious hit. Cuts to NIH, NSF, and most recently the Agency for Healthcare Research and Quality (AHRQ) have created a funding crisis rippling across hospital-based research programs nationwide. AHRQ, informed in July that it would receive no further federal funding, has been operating with a skeleton crew and hasn't awarded a single grant since spring 2025.
The fallout is hitting both current researchers and the next generation of would-be investigators. Experts warn that early-career physicians — already weighing the lower pay and longer training timelines of a research path — may increasingly opt for clinical practice instead, threatening the pipeline of future hospital medicine researchers.
Still, all hope isn't lost. Funding experts and physician-researchers are pointing to alternative sources to keep work moving forward, including PCORI, specialty society grants, biotech and pharma partnerships, and philanthropic organizations.
By the Numbers:
Why it matters: Hospital-based research drives patient safety improvements and healthcare system innovation. As federal dollars shrink, the field risks losing both critical studies and the next generation of researchers — with real consequences for patient care down the line.
